Kaposi Sarcoma

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)

Natural History Study of Kaposi Sarcoma

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Precision Imaging to Evaluate Kaposi Sarcoma

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma

Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Agnostic Therapy in Rare Solid Tumors

Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial

Trial of Ixazomib for Kaposi Sarcoma

Kaposi Sarcoma Chemotherapy and Research (KS-CARE)

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

A Study of Propranolol to Treat Kaposi Sarcoma

Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)